FFF Enterprises Appoints New Business Development Leadership

November 30, 2004 Media Release

TEMECULA, Calif. - FFF Enterprises Inc, a healthcare corporation based in Temecula, Calif., announced today the appointment of new leadership for its business development department, Vice President of Business Development Erik Halstrom. Halstrom is an industry veteran with more than 14 years of service at Merck and Eli Lilly and Co.

"We are very excited to have the talents Erik brings to our team," said Patrick M. Schmidt, president and CEO of FFF Enterprises. "Erik's industry insights and vision will enhance FFF's ongoing investment in our drug development and distribution innovations that are proving so valuable to our customers and partners."

FFF manages and distributes biopharmaceuticals, plasma products and vaccines, and has created some of the industry's leading supply innovations, including the nation's first web-based drug pedigree system.

"I am privileged to be part of a world-class organization with so many great business prospects," Halstrom said. "FFF Enterprises has a long history of creating and implementing pioneering solutions in biopharmaceutical distribution, specialty pharmacy services and electronic data capture solutions that create increasing value for our manufacturing partners. It is exciting to be part of a growing customer-focused organization."

Halstrom has had numerous successes in senior level positions focusing on product and customer marketing, sales, new product planning, national accounts and strategic business relationships. His most recent assignments in Merck's vaccine division include Director of Worldwide Marketing and Planning for new products and Director of Institutional Customer Marketing and Planning.

Halstrom will be working closely with FFF's clinical development electronic data capture company, LifeTree Technology, to create collaborative business development strategies for bringing new drugs to market and for post-market surveillance of existing biopharmaceutical products.